UProtech Overview
- Year Founded
-
2021
- Status
-
Private
- Latest Deal Type
-
Seed
- Investors
-
3
UProtech General Information
Description
Producer of protein degradation drug development in Hangzhou, China. The company focuses on developing next-generation protein-degrading drugs, providing patients with autoimmune disease drug.
Contact Information
Website
u-protech.comCorporate Office
- 3rd Floor, Building 1, Huoshui Industrial Park
- No. 95, Binwen Road, Binjiang District
- Hangzhou, Zhejiang
- China
Corporate Office
- 3rd Floor, Building 1, Huoshui Industrial Park
- No. 95, Binwen Road, Binjiang District
- Hangzhou, Zhejiang
- China
UProtech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Seed Round | 02-Sep-2022 | Completed | Startup |
UProtech Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Shanghai Healthcare Capital | PE/Buyout | Minority | ||
| Shangshi Venture Investment | Corporate Venture Capital | Minority | ||
| Zheshang Venture Capital | Venture Capital | Minority |
UProtech FAQs
-
When was UProtech founded?
UProtech was founded in 2021.
-
Where is UProtech headquartered?
UProtech is headquartered in Hangzhou, China.
-
What industry is UProtech in?
UProtech’s primary industry is Drug Discovery.
-
Is UProtech a private or public company?
UProtech is a Private company.
-
What is UProtech’s current revenue?
The current revenue for UProtech is .
-
Who are UProtech’s investors?
Shanghai Healthcare Capital, Shangshi Venture Investment, and Zheshang Venture Capital have invested in UProtech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process